Literature DB >> 35864325

Community-based outpatient rehabilitation for the treatment of breast cancer-related upper extremity disability: an evaluation of practice-based evidence.

Kelley Covington Wood1, Mary Hidde2,3, Tiffany Kendig2, Mackenzi Pergolotti2,4,5.   

Abstract

PURPOSE: To evaluate the impact and acceptability of outpatient physical or occupational therapy (PT/OT) for breast cancer survivors (BCS) with varying levels of upper extremity disability (UED).
METHODS: We retrospectively extracted patient and therapy characteristics, UED measured by quick-disabilities of the arm, shoulder and hand (QuickDASH, 0-100 pts.), and patient-rated acceptability (1-item, 0-10 pts) from rehabilitation charts of BCS who completed cancer-specialized PT/OT provided by a single national institution in 2019. We summarized characteristics and acceptability using descriptive statistics, then used established parameters to group BCS by baseline UED severity: high- (QuickDASH > 31.5), moderate- (QuickDASH = 18.5-31.5), or low-UED (QuickDASH = 13-18.5). To evaluate within-group pre-to-post QuickDASH change, we used paired samples t test (p < 0.01), then calculated the proportion who achieved the minimally clinical important difference (MCID, 15.9 points). To compare between-groups difference in QuickDASH improvement, we used Kruskal-Wallis test and Chi-squared test.
RESULTS: Patients (N = 417) were 59.89 ± 12.06 years old, 99% female, and attended approximately 10 PT/OT sessions (IQR = 6.0-16.0). Most had high baseline UED (62%), followed by moderate (25%) or low UED (13%). For each severity group, mean pre-to-post change in QuickDASH was significant: high-UED (M∆ = 25.13 ± 20.33, d = 1.24, p < 0.01), moderate-UED (M∆ = 11.36 ± 11.9, d = 0.95, p < 0.01), and low-UED (M∆ = 4.84 ± 9.15, d = 0.53, p < 0.01). Most with high UED achieved the MCID (n = 176, 68.2%). In the moderate- and low-UED groups 44% (n = 46) and 4% (n = 2) achieved the MCID, respectively. Acceptability was high (n = 167, Median = 10).
CONCLUSION: Outpatient cancer rehabilitation is associated with significant improvement in UED for BCS and was acceptable to patients regardless of UED severity at baseline.
© 2022. The Author(s), under exclusive licence to The Japanese Breast Cancer Society.

Entities:  

Keywords:  Breast neoplasms; Health services evaluation; Outpatients; Patient-reported outcome measures; Rehabilitation

Year:  2022        PMID: 35864325     DOI: 10.1007/s12282-022-01388-4

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   3.307


  20 in total

1.  Next-Generation Cancer Rehabilitation: A Giant Step Forward for Patient Care.

Authors:  Catherine M Alfano; Mackenzi Pergolotti
Journal:  Rehabil Nurs       Date:  2018 Jul/Aug       Impact factor: 1.625

2.  A health services research agenda to fully integrate cancer rehabilitation into oncology care.

Authors:  Mackenzi Pergolotti; Catherine M Alfano; Alison N Cernich; K Robin Yabroff; Peter R Manning; Janet S de Moor; Erin E Hahn; Andrea L Cheville; Supriya G Mohile
Journal:  Cancer       Date:  2019-08-07       Impact factor: 6.860

3.  Health Services Research in Rehabilitation and Disability-The Time is Now.

Authors:  James E Graham; Addie Middleton; Pamela Roberts; Trudy Mallinson; Janet Prvu-Bettger
Journal:  Arch Phys Med Rehabil       Date:  2017-08-04       Impact factor: 3.966

4.  Comparison of Upper Extremity Function in Women With and Women Without a History of Breast Cancer.

Authors:  Mary Insana Fisher; Gilson Capilouto; Terry Malone; Heather Bush; Timothy L Uhl
Journal:  Phys Ther       Date:  2020-03-10

Review 5.  Effectiveness of postoperative physical therapy for upper-limb impairments after breast cancer treatment: a systematic review.

Authors:  An De Groef; Marijke Van Kampen; Evi Dieltjens; Marie-Rose Christiaens; Patrick Neven; Inge Geraerts; Nele Devoogdt
Journal:  Arch Phys Med Rehabil       Date:  2015-01-13       Impact factor: 3.966

Review 6.  Stakeholder perspectives on dissemination and implementation of a prospective surveillance model of rehabilitation for breast cancer treatment.

Authors:  Nicole L Stout; Kimberly Andrews; Jill M Binkley; Kathryn H Schmitz; Robert A Smith
Journal:  Cancer       Date:  2012-04-15       Impact factor: 6.860

7.  A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection.

Authors:  Jan J Kootstra; Pieter U Dijkstra; Hans Rietman; Jaap de Vries; Peter Baas; Jan H B Geertzen; Harald J Hoekstra; Josette E H M Hoekstra-Weebers
Journal:  Breast Cancer Res Treat       Date:  2013-04-16       Impact factor: 4.872

Review 8.  American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.

Authors:  Carolyn D Runowicz; Corinne R Leach; N Lynn Henry; Karen S Henry; Heather T Mackey; Rebecca L Cowens-Alvarado; Rachel S Cannady; Mandi L Pratt-Chapman; Stephen B Edge; Linda A Jacobs; Arti Hurria; Lawrence B Marks; Samuel J LaMonte; Ellen Warner; Gary H Lyman; Patricia A Ganz
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544

Review 9.  The importance of patient-reported outcomes in clinical trials and strategies for future optimization.

Authors:  Rebecca Mercieca-Bebber; Madeleine T King; Melanie J Calvert; Martin R Stockler; Michael Friedlander
Journal:  Patient Relat Outcome Meas       Date:  2018-11-01

10.  Upper extremity disability and quality of life after breast cancer treatment in the Greater Plains Collaborative clinical research network.

Authors:  Elizabeth A Chrischilles; Danielle Riley; Elena Letuchy; Linda Koehler; Joan Neuner; Cheryl Jernigan; Brian Gryzlak; Neil Segal; Bradley McDowell; Brian Smith; Sonia L Sugg; Jane M Armer; Ingrid M Lizarraga
Journal:  Breast Cancer Res Treat       Date:  2019-03-09       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.